FDA Approves At-Home Belimumab Injection for Children with Lupus Nephritis Dr. Kamal Kant Kohli25 Jun 2025 10:00 PM ISTThe FDA has approved a 200 mg/mL autoinjector of belimumab (Benlysta) for at-home subcutaneous use in children aged 5 years and older with active...
JAMA: Oral mizoribine with glucocorticoids safe and effective for treatment initiation in lupus nephritis Jacinthlyn Sylvia3 April 2025 9:15 PM ISTA new study published in the Journal of American Medical Association showed that when taken with glucocorticoids for induction treatment of active...
Roche Gazyva application accepted by USFDA for lupus nephritis Ruchika Sharma5 March 2025 1:45 PM ISTGazyva/Gazyvaro is an anti-CD20 monoclonal antibody in a randomised phase III study to demonstrate a CRR benefit in lupus nephritis.
Osteoporosis Common Among Postmenopausal Lupus Nephritis Patients, Study Shows Medha Baranwal5 Dec 2024 8:45 PM ISTChina: A recent cross-sectional study conducted in China reveals a significant prevalence of osteoporosis among patients with lupus nephritis (LN),...
Recommendations for screening, treatment, and management of lupus nephritis: New ACR guideline summary Dr. Kamal Kant Kohli2 Dec 2024 4:14 PM ISTWashington: During ACR Convergence 2024, the American College of Rheumatology (ACR) unveiled a summary of the 2024 Guideline for the Screening,...
Kezar to terminate mid-stage trial for Lupus treatment MD Bureau20 Oct 2024 9:30 AM ISTThe regulator's decision came after the company paused the study in September to review safety data following the deaths of four patients.
High Dose Glucocorticoids Improve Renal Outcomes but Increase Infection and Mortality in Lupus Nephritis: Study Dr Riya Dave26 Jun 2024 6:00 AM ISTResearchers have found that higher doses of glucocorticoids during initial therapy for lupus nephritis (LN) lead to improved renal outcomes but are...
Vigorous Exercise Linked to Reduced Non-Exercise Activity and Weight Gain, reveals study Dr Riya Dave18 Jun 2024 9:00 AM ISTResearchers have found that vigorous exercise, while beneficial for overall health, may lead to reduced non-exercise physical activity (NEPA) and...
CDSCO Panel Grants AstraZeneca's Protocol Amendment Proposal for Anifrolumab Dr. Divya Colin4 Jan 2024 5:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation CDSO has approved the drug major's...
Voclosporin safe and efficacious for long-term use in managing lupus nephritis patients: AURORA 2 Trial Aditi17 Oct 2023 10:45 AM ISTNearly 50 % of patients with a history of systemic lupus erythematosus (SLE) suffer from Lupus nephritis (LN). The likelihood of mortality is...
High dose Anifrolumab Effective for Treatment of Lupus Nephritis Jacinthlyn Sylvia26 Sept 2023 9:45 AM ISTA two-year phase II TULIP-LN trial (NCT02547922) demonstrated the safety and efficacy of anifrolumab in treating active lupus nephritis, with the...
Intestinal microflora linked to lupus nephritis flares Dr. Kamal Kant Kohli29 Jun 2023 8:00 PM ISTUSA: A recent study published in Annals of the Rheumatic Diseases revealed an association between "blooms" of Ruminococcus gnavus, a microbial...
